The current price of TRUMY is $15.90 — it has decreased by 2.96% since the previous close. Data as of Nov 6, 2026.
TRUMY is up 4.16% over the past week, up 8.42% over the past month and down 0.84% over the past year. The price is above its 200-day moving average of $14.02.
Terumo Corporation has a market capitalization of $23.45B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Terumo Corporation posted earnings of $0.30 per share against an estimate of $0.17, beating expectations by 76.47%. Upcoming reports are listed in the earnings calendar.
Terumo Corporation reported revenue of $1.96B in its most recent quarter, which has increased by 11.54% compared with the same quarter a year earlier. Analysts had expected $1.84B.
Yes. Terumo Corporation pays dividends semi-annually. The latest payment of $0.09569 per share has a payment date of Dec 2, 2026, which corresponds to a dividend yield of 1.30%.
Companies most comparable to Terumo Corporation include Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, APT Medical Inc. and Penumbra, Inc.
In the latest trading session TRUMY moved between $15.84 and $16.03, a range of 1.19% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Terumo Corporation shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Terumo Corporation is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks TRUMY has traded between $12.08 and $16.99. The current price is 6.44% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.